Endocrinology, Vol 137, 2126-2132, Copyright © 1996 by Endocrine Society

ARTICLES

Coordinated expression of tissue-type plasminogen activator and plasminogen activator inhibitor type 1 during corpus luteum formation and luteolysis in the adult pseudopregnant rat

K Liu, A Brandstrom, YX Liu, T Ny and G Selstam
Department of Medical Biochemistry and Biophysics, University of Umea, Sweden.

Proteolytic activity generated by the plasminogen activator (PA) system is associated with many biological processes. Using an adult pseudopregnant rat model, we have studied how two components of the PA system, tissue-type plasminogen activator (tPA) and plasminogen activator inhibitor type 1 (PAI-1), are expressed temporally and spatially during different developmental stages of the corpus luteum (CL). Northern blot analysis, in situ hybridization, in situ zymography, and fibrin overlay were used to analyze the expression and distribution of tPA and PAI-1 messenger RNA (mRNA) as well as PA activity in CL of different ages. We demonstrated that during the luteinization period (approximately days 1-2), tPA mRNA was highly and evenly expressed in newly formed CL, whereas PAI-1 mRNA was mainly detected in the central part of the same CL. In accordance with these findings, proteolytic activity generated by tPA was detected in the outer region of newly formed CL by in situ zymography. During the luteotropic period (approximately days 3-10), tPA mRNA expression was very low. PAI-1 mRNA expression was also low, but increased on day 10. As expected, proteolytic activity was very low during this period. During functional luteolysis (days 13-14) and subsequent structural luteolysis, tPA mRNA was elevated. PAI-1 mRNA was also expressed during this period. Moreover, the net PA activity, as determined by fibrin overlay, was relatively high during this period. Our studies indicate that tPA and PAI-1 are coordinately expressed in the CL, resulting in increased proteolytic activities during the luteinization and luteolytic periods. PA-mediated proteolysis may, therefore, play a role in both CL formation and luteolysis in rats.

This article has been cited by other articles:

				H. Zhang, H.-Y. Lin, Q. Yang, H.-X. Wang, K. X. Chai, L.-M. Chen, and C. Zhu Expression of Prostasin Serine Protease and Protease Nexin-1 (PN-1) in Rhesus Monkey Ovary During Menstrual Cycle and Early Pregnancy J. Histochem. Cytochem., December 1, 2007; 55(12): 1237 - 1244. [Abstract] [Full Text] [PDF]

				J. K Devin, J. E Johnson, M. Eren, L. A Gleaves, W. S Bradham, J. R Bloodworth Jr, and D. E Vaughan Transgenic overexpression of plasminogen activator inhibitor-1 promotes the development of polycystic ovarian changes in female mice J. Mol. Endocrinol., July 1, 2007; 39(1): 9 - 16. [Abstract] [Full Text] [PDF]

				P. Wahlberg, I. Boden, J. Paulsson, L. R. Lund, K. Liu, and T. Ny Functional Corpora Lutea Are Formed in Matrix Metalloproteinase Inhibitor-Treated Plasminogen-Deficient Mice Endocrinology, March 1, 2007; 148(3): 1226 - 1234. [Abstract] [Full Text] [PDF]

				L. Liu, S. Rajareddy, P. Reddy, C. Du, K. Jagarlamudi, Y. Shen, D. Gunnarsson, G. Selstam, K. Boman, and K. Liu Infertility caused by retardation of follicular development in mice with oocyte-specific expression of Foxo3a Development, January 1, 2007; 134(1): 199 - 209. [Abstract] [Full Text] [PDF]

				M. Cao, M. Sahmi, J. G. Lussier, and C. A. Price Plasminogen Activator and Serine Protease Inhibitor-E2 (Protease Nexin-1) Expression by Bovine Granulosa Cells In Vitro Biol Reprod, September 1, 2004; 71(3): 887 - 893. [Abstract] [Full Text] [PDF]

				Y.-X. Liu, K. Liu, Q. Feng, Z.-Y. Hu, H.-Z. Liu, G.-Q. Fu, Y.-C. Li, R.-J. Zou, and T. Ny Tissue-Type Plasminogen Activator and Its Inhibitor Plasminogen Activator Inhibitor Type 1 Are Coordinately Expressed during Ovulation in the Rhesus Monkey Endocrinology, April 1, 2004; 145(4): 1767 - 1775. [Abstract] [Full Text] [PDF]

				K. Liu, Q. Feng, H.-J. Gao, Z.-Y. Hu, R.-J. Zou, Y.-C. Li, and Y.-X. Liu Expression and Regulation of Plasminogen Activators, Plasminogen Activator Inhibitor Type-1, and Steroidogenic Acute Regulatory Protein in the Rhesus Monkey Corpus Luteum Endocrinology, August 1, 2003; 144(8): 3611 - 3617. [Abstract] [Full Text] [PDF]

				S. Hasan, G. Hosseini, M. Princivalle, J.-C. Dong, D. Birsan, C. Cagide, and A. I. de Agostini Coordinate Expression of Anticoagulant Heparan Sulfate Proteoglycans and Serine Protease Inhibitors in the Rat Ovary: A Potent System of Proteolysis Control Biol Reprod, January 1, 2002; 66(1): 144 - 158. [Abstract] [Full Text]

				K. Liu, J. I. Olofsson, P. Wahlberg, and T. Ny Distinct Expression of Gelatinase A [Matrix Metalloproteinase (MMP)-2], Collagenase-3 (MMP-13), Membrane Type MMP 1 (MMP-14), and Tissue Inhibitor of MMPs Type 1 Mediated by Physiological Signals During Formation and Regression of the Rat Corpus Luteum Endocrinology, November 1, 1999; 140(11): 5330 - 5338. [Abstract] [Full Text]

				J. A. McCracken, E. E. Custer, and J. C. Lamsa Luteolysis: A Neuroendocrine-Mediated Event Physiol Rev, April 1, 1999; 79(2): 263 - 323. [Abstract] [Full Text] [PDF]

				E. Bjurulf, O. Toffia, G. Selstam, and J. I. Olofsson Luteolysis Induced by a Prostaglandin F2{alpha} Analogue Occurs Independently of Prolactin in the Rat Biol Reprod, July 1, 1998; 59(1): 17 - 21. [Abstract] [Full Text]